The Type of Hepatoglobin in IUGR
NCT02127385 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2014-04-30
Summary
Intra Uterine Growth Restriction is associated with increased oxidative stress. Haptoglobin (Hp) is an abundant plasma glycoprotein produced in the liver. The function of Hp is as anti oxidant agent, it binds free hemoglobin (Hb) released from red blood cells to decrease oxidative tissue damage. There are 3 differenet genotype of haptoglobin Hp 1-1 Hp 1-2 and Hp 2-2 with different anti oxidant properties and different prevalence ( Hp 1-1, Hp 1-2 and Hp 2-2approximately 16%, 48% and 36% respectively) . we hypotheise that IUGR will be more common and severe in the Hp 2-2 genotype with the less anti oxidant properties.
Conditions
- Haptoglobin Type
Sponsors & Collaborators
-
Hillel Yaffe Medical Center
lead OTHER_GOV
Principal Investigators
-
RON BELOOSESKY, M.D · HILLEL YAFFE MEDICAL CENTER- TECHNION
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-04-30
- Primary Completion
- 2015-04-30
More Related Trials
-
Haptoglobin and Diabetes Complications in Pregnancy
NCT01758016 ·Status: UNKNOWN
-
Maternal alpha1 Antitrypsin as a Marker of Intrauterine Growth Restriction in Pre-eclamptic Women
NCT05622838 ·Status: UNKNOWN
-
The Levels of the Orexin, Galanin and aMSH and CART in Patients With Hyperemesis Gravidarum
NCT05446025 ·Status: COMPLETED
-
Haptoglobin and Preeclampsia
NCT01027130 ·Status: COMPLETED
-
qCTG and Doppler Ultrasound in the Detection of Hypoxia Among FGR Fetuses
NCT04447248 ·Status: COMPLETED
-
Thromboelastography (TEG) In the Intrauterine Growth Restriction (IUGR) Neonatal Population by Gestational Age
NCT04907578 ·Status: WITHDRAWN
-
L-Arginine Treatment for Severe Vascular Fetal Intrauterine Growth Restriction: a Randomized Double Bind Controlled Trial (L Arginine in IUGR)
NCT00549575 ·Status: TERMINATED ·Phase: PHASE3
-
Prediction of Preeclampsia & Other Obstetric Complications by Serum Homocysteine & Doppler
NCT02541110 ·Status: UNKNOWN
-
CGH-array in Prenatal Diagnosis of Isolated Severe and Early Intra-uterine Growth Restriction
NCT04729361 ·Status: UNKNOWN
-
Ultra-early Identification of Fetal Chromosomal Characteristics From Extravillous-trophoblast Cells
NCT06523543 ·Status: RECRUITING
-
Inflammation Markers in Hyperemesis Gravidarum
NCT06245811 ·Status: COMPLETED
-
Uterine Artery Pulsatility Index and Materno Fetal Outcomes
NCT02853058 ·Status: UNKNOWN ·Phase: NA
-
Non-invasive Placental Chromosome Exploration of Intrauterine Growth Restriction
NCT05023161 ·Status: RECRUITING
-
Low Molecular Weight Heparin in Pregnancies With Unexplained Stillbirths
NCT03601338 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Determination of Abnormal Fetal Growth or Amniotic Fluid With Third Trimester Ultrasounds in Uncomplicated Pregnancies: A Randomized Trial
NCT02702999 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Value of sFlt-1/PlGF Ratio for the Etiology of Intra Uterine Growth Restriction - ANGIOPAG
NCT05151289 ·Status: UNKNOWN ·Phase: NA
-
Maternal-fetal Outcomes of Genital Blood Loss Beyond 18 Weeks of Pregnancy
NCT06802874 ·Status: RECRUITING
-
Validating a New Point-of-care Device for Estimation of Blood Count in Pregnant Women
NCT05012202 ·Status: COMPLETED
-
Can Low Molecular Weight Heparin During Pregnancy With Intrauterine Growth Restriction Increase Birth Weight?
NCT01390051 ·Status: COMPLETED ·Phase: PHASE4
-
Placental Imaging Techniques
NCT06861309 ·Status: RECRUITING ·Phase: NA
-
Prediction of Placenta Accreta Outcome in Pregnant Woman With Placenta Previa Using (hcg_h ) as Abiomarkers
NCT06761885 ·Status: NOT_YET_RECRUITING
-
Genetic Polymorphisms of ABCB11 and ABCB4 in Women With Intrahepatic Cholestasis of Pregnancy (ICP) and in Their First Degree Relatives
NCT04281082 ·Status: UNKNOWN
-
Predicting Placental Pathologies by Ultrasound Imaging
NCT04506970 ·Status: COMPLETED
-
THROmbinography in Pregnant Woman and in Vitro Action of Low Molecular Weight HEparin
NCT06575309 ·Status: RECRUITING
-
First Trimester Placental Assessment in the Screening of Preeclampsia and Intrauterine Growth Restriction
NCT02879942 ·Status: COMPLETED